Biomatics Capital Partners
Venture capital · Seattle, Washington, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
3Deep-tech portfolio1 active
2Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Absci
12Co-investorsShare a portfolio company
Portfolio · 3 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Nautilus Biotechnology | Biotech | Active | — | — |
| Absci | Biotech | Public | Mar 30, 2021 | $216.0M |
| Vividion Therapeutics | Biotech | Acquired | Mar 2, 2021 | $240.7M |
Peer ranks
Portfolio size#136
Portfolio exits#103
Raises, 12 months#88
Co-investors#150
Co-investors
- RA CapitalVenture capital3 shared
- Biotechnology Value FundVenture capital2 shared
- Casdin CapitalVenture capital2 shared
- Northpond VenturesVenture capital2 shared
- Agilent TechnologiesVenture capital1 shared
- Bessemer Venture PartnersVenture capital1 shared
- Boxer CapitalVenture capital1 shared
- DCVC BioVenture capital1 shared
- EcoR1 CapitalVenture capital1 shared
- Frazier Healthcare PartnersVenture capital1 shared
Sectors
- Biotech3
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.